Viridian Therapeutics, Inc.
Viridian Therapeutics, Inc.（VRDN）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
vrdn · 股价预测 · 16 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 16 位华尔街分析师
Buy
16 位分析师
共识
评级分布
12 个月目标价
High
$50.00
Consensus
$36.86
+134.3% upside
Low
$26.00
Median: $34 · Last Close: $15.73
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$36.86
134.3% upside
High Target
$50
217.9%
Low Target
$26
65.3%
Current Price
$15.73
as of today
Based on analyst price targets, the VRDN stock price prediction for the next 12 months ranges from $26 to $50. The consensus VRDN price forecast of $36.86 implies 134.3% upside from the current price of $15.73.
短期股价预测
Bear算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $15.11 | ↓ 3.96% |
1-day model range: $14.85–$15.36. Peak: $15.36 (-3.96%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $14 | -9.3% |
| 2028 | $14 | -13.9% |
| 2029 | $13 | -16.3% |
| 2030 | $13 | -17.6% |
| 2031 | — | -18.3% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · VRDN · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-15 | Evercore ISI Group | Maintains | Outperform→Outperform |
| 2026-05-06 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-05-05 | Needham | Maintains | Buy→Buy |
| 2026-04-21 | Truist Securities | Maintains | Buy→Buy |
| 2026-04-08 | Wedbush | Maintains | Outperform→Outperform |
| 2026-04-07 | Goldman Sachs | Maintains | Buy→Buy |
| 2026-04-07 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-04-02 | Evercore ISI Group | Maintains | Outperform→Outperform |
| 2026-03-31 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-31 | Goldman Sachs | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Viridian Therapeutics, Inc. (VRDN) stock. Of the recent 114 rating actions, 0 were upgrades and 3 were downgrades. 16 analysts currently cover VRDN.
分析师推荐趋势
VRDN analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 3 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$46M
↓ 92.1% YoY
Revenue Next Year
$244M
↑ 431.1% YoY
EPS This Year
$-3.77
EPS Next Year
$-2.42
↓ 35.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast VRDN EPS of $-3.77 for the current fiscal year, based on estimates from 10 analysts. The VRDN revenue forecast is $46M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
VRDN 股价预测由两类独立数据源支撑：来自 16 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。VRDN 的共识目标价为 $36.86（+134.3% 上行空间），分析师共识为 Buy。
VRDN 的短期预测（明日）为 $15.11（-3.96%）。 VRDN 对 2027 年的股价预测均值为 $14。 VRDN 对 2030 年的预测区间为 $11–$15。
Viridian Therapeutics, Inc. 在 NASDAQ 上市，代码 VRDN。VRDN 在 2027 年的整体展望偏积极，在覆盖分析师中约 81% 对应 Buy 共识。
常见问题
VRDN 预测 · 8 个问题根据 16 位华尔街分析师，VRDN 的 12 个月平均目标价为 $36.86，最高 $50.00、最低 $26.00。若有图表，中位目标价可在上方查看。相对当前价 $15.73，隐含约 +134.3% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.